Open Access

[Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells

  • Authors:
    • Qu Yang
    • Shanyong Zhang
    • Mingyang Kang
    • Rongpeng Dong
    • Jianwu Zhao
  • View Affiliations

  • Published online on: July 16, 2021     https://doi.org/10.3892/or.2021.8144
  • Article Number: 193
  • Copyright : © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

September-2021
Volume 46 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang Q, Zhang S, Kang M, Dong R and Zhao J: [Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells. Oncol Rep 46: 193, 2021
APA
Yang, Q., Zhang, S., Kang, M., Dong, R., & Zhao, J. (2021). [Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells. Oncology Reports, 46, 193. https://doi.org/10.3892/or.2021.8144
MLA
Yang, Q., Zhang, S., Kang, M., Dong, R., Zhao, J."[Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells". Oncology Reports 46.3 (2021): 193.
Chicago
Yang, Q., Zhang, S., Kang, M., Dong, R., Zhao, J."[Retracted] Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells". Oncology Reports 46, no. 3 (2021): 193. https://doi.org/10.3892/or.2021.8144